Scienture Holdings (SCNX) Profit After Tax (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Profit After Tax came in at -$2.8 million in Q2 2026, up 58.0% year-over-year from -$1.8 million in Q2 2025, and up 17.04% quarter-over-quarter from -$3.4 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Profit After Tax (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Profit After Tax across 14 years of filings, most recently posting -$2.8 million for Q2 2026.
- In Q2 2026, Profit After Tax rose 58.0% year-over-year to -$2.8 million; the TTM figure through Jun 2026 stood at -$16.0 million (down 266.29% YoY), while the FY2025 annual figure was -$41.5 million, down 113.32% from the prior year.
- Profit After Tax came in at -$2.8 million for Q2 2026 at Scienture Holdings, up from -$3.4 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $21.2 million in Q1 2024 to a low of -$11.7 million in Q4 2023.
- Average Profit After Tax over 5 years is -$1.3 million, with a median of -$2.0 million recorded in 2023.
- Year-over-year, Profit After Tax plunged 799.13% in 2023 and surged 3233.85% in 2024.
- Over 5 years, Profit After Tax stood at -$1.3 million in 2022, then sank by 799.13% to -$11.7 million in 2023, then jumped by 84.35% to -$1.8 million in 2024, then sank by 266.46% to -$6.7 million in 2025, then jumped by 58.0% to -$2.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$2.8 million in Q2 2026, -$3.4 million in Q1 2026, and -$6.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -576.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -118.80 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 45.93 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 69.61 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 260.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 24.71 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -66.82 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 30.35 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 1.97 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | -2.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.82 Mn |
| Mar 31, 2026 | -3.40 Mn |
| Jun 30, 2025 | -6.72 Mn |
| Mar 31, 2025 | -3.06 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Mar 31, 2024 | 21.25 Mn |
| Dec 31, 2023 | -11.72 Mn |
| Sep 30, 2023 | -3.53 Mn |
| Jun 30, 2023 | -2.23 Mn |
| Mar 31, 2023 | -677,953.00 |
| Dec 31, 2022 | -1.30 Mn |
| Sep 30, 2022 | -528,742.00 |
| Jun 30, 2022 | -1.11 Mn |
| Mar 31, 2022 | -965,836.00 |
| Dec 31, 2021 | -784,340.00 |
| Sep 30, 2021 | -1.30 Mn |
| Jun 30, 2021 | -2.58 Mn |
| Mar 31, 2021 | -651,519.00 |
| Dec 31, 2020 | -2.31 Mn |
| Sep 30, 2020 | 138,391.00 |